MLI's TikToktivityTM CE like you've never seen before
One educational initiative. Two learning paths.
Earn up to 1.25 CME, AAPA, ABIM MOC Credit
Accreditation Statement
In support of improving patient care, Medical Learning Institute Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Commercial Support Statement
This activity is supported by an educational grant from Bristol Myers Squibb.
Click on each activity link below for full CE information including disclosures.
For hematologists/oncologists, the initiative addresses the real-world burden of anemia in LR-MDS, risk assessment tools, genetic mutations influencing treatment, safety and efficacy trial data of therapeutic options, monitoring and mitigating adverse events, and the importance of interdisciplinary care teams in optimizing patient outcomes.
For primary care providers, the initiative emphasizes recognizing anemia, ensuring timely care and referrals to specialists, understanding the impact on patient quality of life, managing comorbidities, available treatment options, identifying adverse events, integrating with interdisciplinary care teams, and creating personalized care plans considering healthcare barriers and shared decision-making.
Sanjay K. Juneja, MD
@theoncdoc
Accurately assess patient and clinical risk factors in the diagnosis and prognosis of LR-MDS to guide treatment decisions that relieve the burden of symptomatic anemia
Joel Alcid, MD
@joelal_md
Evaluate risk factors and stratification criteria for MDS and associated anemia to determine prognosis and treatment strategies
Rahul Gosain, MD, MBA | Rohit Gosain, MD
@oncbrothers
Utilize collaborative approaches to enhance health outcomes for individuals with symptomatic anemia
Mikkael A. Sekeres, MD, MS
@MikkaelSekeres
Appropriately evaluate the efficacy and safety of the newest game-changing therapies to optimize clinical outcomes for patients with symptomatic anemia and LR-MDS
Andrea R. Dean, MD
@andreadeanmd
Develop long-term, individualized care plans for anemia management for patients with LR-MDS
A compilation of the above educational activities for Hematology/Oncology learners that will enable them to better:
- Accurately assess patient and clinical risk factors in the diagnosis and prognosis of LR-MDS to guide treatment decisions that relieve the burden of symptomatic anemia
- Evaluate risk factors and stratification criteria for MDS and associated anemia to determine prognosis and treatment strategies
- Utilize collaborative approaches to enhance health outcomes for individuals with symptomatic anemia
- Appropriately evaluate the efficacy and safety of the newest game-changing therapies to optimize clinical outcomes for patients with symptomatic anemia and LR-MDS
- Develop long-term, individualized care plans for anemia management for patients with LR-MDS
Jennifer N. Caudle, DO, FACOFP
@drjencaudle
Identify the role of the primary care provider in the coordination of care for patients with anemia including proper evaluation and referral
Jason Singh, MD
@drjaysonisfresh
Appropriately evaluate the underlying causes of anemia, including a suspected hematologic malignancy such as MDS
W. Scott Metcalfe, MD, FACS
@drscottmetcalfe
Develop a plan to appropriately evaluate, manage and refer your patient with anemia when MDS is expected using clinical guidelines and best practices
Lauren Powell, MD
@drlaurenpowell
Appropriately evaluate efficacy and safety trial data of groundbreaking therapies to optimize clinical outcomes for patients with symptomatic anemia and LR-MDS
Contessa Metcalfe, MD, MSPH
@drcontessa
Develop long-term, individualized care plans for anemia management for patients with LR-MDS.
A compilation of the above educational activities for PCP learners that will enable them to better:
- Identify the role of the primary care provider in the coordination of care for patients with anemia including proper evaluation and referral
- Appropriately evaluate the underlying causes of anemia, including a suspected hematologic malignancy such as MDS
- Develop a plan to appropriately evaluate, manage and refer your patient with anemia when MDS is expected using clinical guidelines and best practices
- Appropriately evaluate efficacy and safety trial data of groundbreaking therapies to optimize clinical outcomes for patients with symptomatic anemia and LR-MDS
- Develop long-term, individualized care plans for anemia management for patients with LR-MDS